Composition for treating contact dermatitis comprising pellitorine as an active ingredient

The present invention relates to a composition including pellitorine as an active ingredient for alleviating contact dermatitis. A pellitorine compound which is an active ingredient of the composition according to the present invention is secreted in the early stage of various strong inflammatory diseases so as to control the secretion of IL-1beta which is cytokine promoting an inflammatory response and also control the proliferation of T cells and the secretion of IL-2, IL-4, or IFN-gamma which is cytokine secreted from T cells so that immunity can be regulated. Moreover, the compound exhibits activities in controlling the secretion of IL-1beta, inhibiting the decomposition cleavage of caspase-1, having no cytotoxicity, and decreasing skin thickness in contact dermatitis in an experiment using a contact dermatitis animal model as an animal model. Accordingly, it is expected that the composition of the present invention can be usefully used as a pharmaceutical composition, a cosmetic composition, or a functional food composition for preventing or treating inflammatory skin diseases like contact dermatitis.